We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Medpace Announces Plans to Enter Into an Equity Recapitalization with Affiliates of CCMP Capital Advisors
News

Medpace Announces Plans to Enter Into an Equity Recapitalization with Affiliates of CCMP Capital Advisors

Medpace Announces Plans to Enter Into an Equity Recapitalization with Affiliates of CCMP Capital Advisors
News

Medpace Announces Plans to Enter Into an Equity Recapitalization with Affiliates of CCMP Capital Advisors

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Medpace Announces Plans to Enter Into an Equity Recapitalization with Affiliates of CCMP Capital Advisors"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Medpace, Inc. has announced a plan to complete an equity recapitalization with affiliates of CCMP Capital Advisors, LLC. This relationship will allow Medpace to add global operational depth and continue their reputation as a company well known for therapeutic and operational excellence in conducting Phase I-IV clinical studies.

"Our relationship with CCMP will bring many benefits to our customers, employees, and shareholders," said August Troendle, President and CEO, Medpace.

"The transaction will provide resources to make the strategic long-term investments that are needed to advance our leadership position, grow the core business, and expand our global reach."

Medpace expects to finalize the deal in June 2011. Following the closing, CCMP will own 80% of the company and the current Medpace management team will own a 20% equity share.

August J. Troendle will remain as the President and CEO and the current management team will remain in place. Medpace will continue to be headquartered in Cincinnati, OH.

Advertisement